Company · CIK 0000908259 · SIC 2834 — Pharmaceutical Preparations · OTC
Oncotelic Therapeutics, Inc. · OTLC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 PForm 4 → | Jul 2, 3:00 pm EDT | Vuong TrieuCHAIRMAN AND CEO, Director, 10% Owner | 240,000 | $0.0431 | $10,344 | 94,124,319 | +0.26% | |
| Jun 22, 2026 PForm 4 → | Jun 24, 8:37 pm EDT | Vuong TrieuCHAIRMAN AND CEO, Director, 10% Owner | 255,000 | $0.045 | $11,475 | 93,694,319 | +0.27% | |
| Jun 22, 2026 PForm 4 → | Jun 22, 4:30 pm EDT | Amit B. ShahCFO | 20,000 | $0.05 | $1,000 | 378,837 | +5.57% | |
| Jun 15, 2026 PForm 4 → | Jun 17, 7:34 pm EDT | Vuong TrieuCHAIRMAN AND CEO, Director, 10% Owner | 335,759 | $0.0447 | $15,013 | 93,389,560 | +0.36% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 AForm 4 → | Jul 23, 4:00 pm EDT | Seymour Howard FeinCRO/CMO | 250 | — | — | 250 | — | late |
| Jul 10, 2026 AForm 4 → | Jul 21, 4:00 pm EDT | Steven W KingDirector | 250 | — | — | 250 | — | late |
| Jul 10, 2026 AForm 4 → | Jul 14, 4:00 pm EDT | Anthony E Maida IIIDIRECTOR AND CMO - TRANS. MED., Director | 1,500 | — | — | 1,500 | — | |
| Jul 10, 2026 AForm 4 → | Jul 14, 4:00 pm EDT | Saran SaundCBO | 1,500 | — | — | 1,500 | — | |
| Jul 10, 2026 AForm 4 → | Jul 14, 4:00 pm EDT | Amit B. ShahCFO | 1,500 | — | — | 1,500 | — | |
| Jul 10, 2026 AForm 4 → | Jul 14, 4:00 pm EDT | Vuong TrieuCHAIRMAN AND CEO, Director, 10% Owner | 2,000 | — | — | 2,000 | — |